More heart failure patients will be taking an aldosterone antagonist

November 2003

More heart failure patients will be taking an aldosterone antagonist...spironolactone or the new Inspra (eplerenone).

Spironolactone improves survival in patients with severe heart failure and reduced left ventricular function.

Inspra improves survival in patients who've had a heart attack and who also have decreased heart function.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

who should take a daily aspirin...and how much they should take
Alzheimer's Disease Memantine (Namenda) just got approved for Alzheimer's
Cardiology new warnings about a potential interaction between cranberry juice and warfarin
Cardiology More heart failure patients will be taking an aldosterone antagonist
Osteoporosis thiazide diuretics reduce the risk of fractures from osteoporosis
Osteoporosis combo treatment for osteoporosis in postmenopausal women
Shingles Does the chickenpox vaccine (Varivax) prevent shingles?
new protease inhibitor called Lexiva
Infectious Diseases antibiotic suspensions that DON'T need refrigeration...DisperMox and Panixine Disperdose
Infectious Diseases new injectable antibiotic called Cubicin
Hematology & Oncology Femara (letrozole) to prevent recurrent breast cancer
Men's Health Levitra will work in some men who don't respond to Viagra
possible link between atypical antipsychotics and diabetes
Zomig NASAL SPRAY
confusion between the new Darvocet A500 and Darvocet-N 100
Medication Errors Look- and sound-alike drug names are creating mistakes